Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
328
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
-601K
-
Total reported value, excl. options
-
$3.1B
-
Value change
-
-$23.2M
-
Put/Call ratio
-
0.07
-
Number of buys
-
159
-
Number of sells
-
-159
-
Price
-
$42.41
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2024
392 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2024.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 328 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
.
Largest 10 shareholders include BlackRock, Inc. (11.1M shares), VANGUARD GROUP INC (7.36M shares), Capital World Investors (3.27M shares), STATE STREET CORP (2.66M shares), ArrowMark Colorado Holdings LLC (2.39M shares), FRED ALGER MANAGEMENT, LLC (1.98M shares), Bellevue Group AG (1.85M shares), GW&K Investment Management, LLC (1.8M shares), JENNISON ASSOCIATES LLC (1.78M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.53M shares).
This table shows the top 328 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.